AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
LAMIVUDINE &TENOFOVIR DISOPROXIL FUMARATE in Malawi
6 products registered with PMRA — 0 active, 6 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LAMIVUDINE_&TENOFOVIR_DISOPROXIL_FUMARATE 300/300MG TABLET TABLET | PMPB/PL167/191 | — | expired | 31 Mar 2025 |
| LAMIVUDINE/TENOFOVIR_DISOPROXIL_FUMARATE 300/300MG TABLET TABLET | PMPB/PL67/142 | — | expired | 31 Mar 2025 |
| DUOMUNE 300/300MG TABLET TABLET | PMPB/PL167/127 | — | expired | 30 Jun 2019 |
| LAMIVUDINE-TENOFOVIR 300MG/300MG TABLET TABLET | PMPB/PL132/92 | — | expired | 30 Jun 2019 |
| DUOMUNE 300/300MG TABLET TABLET | PMPB/PL438/2 | — | expired | 30 Jun 2019 |
| TENOLAM 300MG/300MG TABLET TABLET | PMPB/PL67/103 | — | expired | 30 Jun 2013 |
LAMIVUDINE &TENOFOVIR DISOPROXIL FUMARATE — PMRA Registration Details
PMRA (Malawi) has 6 registered products containing LAMIVUDINE &TENOFOVIR DISOPROXIL FUMARATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track LAMIVUDINE &TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.